Skip to main content
Skip to content
Case File
efta-01520676DOJ Data Set 10Other

EFTA01520676

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01520676
Pages
1
Persons
0
Integrity

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GHISLAINE MAXWELL ACCT. For the Period 5/1/11 to 5/31/I I Equity Summary Asset Categories Beginning Market Value Ending Market Value Change In Value Current Allocation US Large Cap Equity 111559.00 149,122.00 37,563.00 7% US Small/Mkt Cap Equity 14,400.00 13,170.00 (1,230.00) 1% Non-US Equity 66,008.00 65,534.00 496.00 3% Preferred Stocks 169,242.00 169,716.00 474.00 8% Concentrated 8 Other Equity 49.810 00 50.100.00 290.00 2% Total Value 5410,049.00 5447,642.00 $37,593.00 21% Market Value/Cost Current Period Value Market Value 447,642.00 Tax Cost 446,842.92 Unrealized Gain/Loss 799.08 Estimated Annual Income 16,932.50 Accrued Dividends 893.75 Yield 3.78% JP Morgan Asset Categories Proterrod Stocks US Snail Mid Cap Equity Concentrared 8 Other Equity Non-US Equity US Large Cep Equity Equity as a percentage of your portfolio - 21 % Page 4 of 22 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00048003 SDNY_GM_00317201 EFTA01520676

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.